Created - 10.07.2017
Following receiving reports of the deaths of eight patients who received intravenous or intramuscular injections of Buscopan®, the Medicines and Healthcare Products Regulatory Agency (MHRA) issued an alert advising of a very small risk of serious adverse reactions in patients with underlying cardiac disease. This has caused considerable concern in radiology departments around the UK, and in aiming to clarify the current situation, The Royal College of Radiologists (RCR) is extremely grateful to Dr Damian Tolan and Dr Ashley Roberts who have produced this guidance on behalf of the British Society of Gastrointestinal and Abdominal Radiologists (BSGAR).
